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Abstract 
Over the last few years, a vast variety of devices have been developed to close 
various septal defects through the transcatheter route. Haemolysis has been 
documented after Amplatzer device closure of patent ductus arteriousus, atrial septal 
defect, and ventricular septal defect. We report one patient with self-limiting 
haemolysis after implantation of an Amplatzer perimembranous VSD device. 
 
Introduction 
Congenital heart disease encompasses a variety of lesions that may include 
communication/s between the left and the right side of the heart. Such 
communications may cause volume overload in the short and medium term, possibly 
resulting in heart failure, or irreversible complications in the long term such as 
Eisenmenger's syndrome. Previously, such defects (typically atrial (ASD) and 
ventricular septal defects (VSD) and patent ductus arteriosus (PDA)) were closed 
surgically. Over the last decade, a vast variety of devices have been developed to 
close such defects through the transcatheter route. 
We report one patient who had self-limiting haemolysis after implantation of an 
Amplatzer perimembranous VSD device. 
 
Patient 
Our patient was born via normal vaginal delivery at 38 weeks gestation after an 
uneventful preganacy. At the routine 6 week visit, she was noted to be failing to thrive 
and a 3/6 systolic murmur was noted. Echocardiogram done showed a large 
perimembranous VSD. Diuretics were commenced and she throve. At 4 years of age, 
she was admitted to the paediatric surgical ward with fever, abdominal pain and 
vomiting. Surgical exploration of the abdomen under antibiotic cover was normal, as 
was an echocardiogram at this time. Fever persisted and a repeat echocardiogram 
showed tricuspid valve endocarditis with a large vegetation that eventually eroded 
part of the valve resulting in significant regurgitation. The endocarditis was treated 
with antibiotics and transcatheter closure of the VSD was done successfully using a 
14mm Amplatzer perimembranous VSD device at 5 years of age. She was 
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discharged on Aspirin for 6 months. One week after discharge, she was readmitted 
due to jaundice and dark coloured urine. Haemoglobin was 9.5g/dL, liver function 
tests were deranged (bilirubin 80umol/l; direct bilirubin 12umol/l; gamma GT 80 U/l; 
ALT 58 U/l; Alkaline phosphatase 707 U/l, with urobilinogen in the urine. Viral 
studies, inclujding CMV, EBV, Hepatitis A and B, were all negative. She was 
discharged home as after two weeks as her jaundice cleared and her liver function 
tests improved. One transfusion was needed. 
Discussion 
Device closure of septal defects may result in various complications. These include 
endocarditis, device embolisation, cardiac rupture and arrhythmias. 
Haemolysis has been documented after Amplatzer device closure of PDA,1 ASD,2 
and VSD.3 The one reported case after VSD closure resulted in transient renal 
failure.3 Hemolysis has also been associated with the use of Amplatzer devices to 
close paravalvar mitral valve leaks after mitral valve replacement.4 
Conservative treatment is usually sufficient but reintervention of some form may 
occasionally be necessary, such as intradevice coil deployment in order to 
completely eliminate any degree of residual left to right shunting.5 
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